Skip to content

Prospective clinical study on the relationship between frailty score and survival in newly dignosed MM patients

Prospective clinical study on the relationship between frailty score and survival in newly dignosed MM patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067446
Enrollment
Unknown
Registered
2023-01-09
Start date
2023-01-31
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

case series:None

Sponsors

Department of Hematology, Beijing Chaoyang Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) According to IMWG 2014 dignosis criterion, newly diagnosed multiple myeloma patients; 2) Aged over 18;

Exclusion criteria

Exclusion criteria: 1) The comorbidity of other malignant tumors which still need to be treated within 1 year before enrollment, uncontrollable infections, serious physical or mental diseases which may interfere with the participation in this clinical study. 2) Those who cannot understand or comply with the research protocol or cannot sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Correlation between Mayo frailty Model and PFS;

Secondary

MeasureTime frame
Correlation between Mayo frailty Model and OS;Correlation between IMWG frailty Model and PFS;Correlation between IMWG frailty Model and OS;develop a simplified frailty scoring model based on age, ECOG and BNP;

Countries

china

Contacts

Public Contactwen gao

Department of Hematology, Beijing Chaoyang Hospital Affiliated to Capital Medical University

gaowenpingping@163.com13651275440

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026